Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems . Bringing Clarivate domain-specific regulatory insights into Claude to support life ...

Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflowsLONDO ...

Most investors have never heard of Clarivate. The company operates largely outside mainstream investor attention. While the market fixates on AI darlings trading at triple-digit multiples, this London ...

Wolfe Research FinTech Forum March 10, 2026 10:55 AM EDTCompany ParticipantsJonathan Collins - Executive VP & CFOConference ...

Management characterizes 2025 as a positive inflection point, marking the first time since 2019 that the company delivered on its initial full-year financial guidance. The decision to sell the Life ...

On February 17, 2026, HG Vora Capital Management reported selling all of its 11,125,000 shares of Clarivate (NYSE:CLVT) in the fourth quarter. According to its SEC filing dated February 17, 2026, HG ...

BioWorld biopharma clinical, regulatory and conference charts include worldwide news of phase I, phase II and phase III clinical development by biopharmaceutical companies developing therapeutics, as ...

Clarivate Plc CLVT announced Tuesday it will integrate its Cortellis Regulatory Intelligence (CRI) data with Claude, the AI assistant developed by Anthropic, to expand access to trusted regulatory ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.